Fabrication and statistical optimization of surface engineered PLGA nanoparticles for naso-brain delivery of ropinirole hydrochloride: in-vitro–ex-vivo studies

References

• Shadab , AP , Zeenat , IZ , Syed , MA , Sushma , T , Divya , V , Gaurav , KJ , Azeem , A , Nitin , J , Jigar , L , Khar , RK and Ahmad , FJ . 2009 . CNS drug delivery systems: novel approaches . Recent Pat. Drug Deliv. Formul. , 3 : 71 – 89 .
   PubMedGoogle Scholar
• Abbott , NJ and Romero , IA . 1996 . Transporting therapeutics across the blood–brain barrier . Mol. Med. Today. , 2 : 106 – 113 .
   PubMedGoogle Scholar
• Seju , U , Kumar , A and Sawant , KK . 2011 . Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in vitro and in vivo studies . Acta Biomater. , 7 : 4169 – 4176 .
   PubMed Web of Science ®Google Scholar
• Partridge , WM . 1998 . CNS drug design based on principles of blood–brain barrier transport . J. Neurochem. , 70 : 1781 – 1792 .
   PubMedGoogle Scholar
• Johnson , MD , Chen , J and Anderson , BD . 2002 . Investigation of the mechanism of enhancement of central nervous system delivery of 20-beta-fluoro-20, 30-dideoxyinosine via a blood–brain barrier adenosine deaminase-activated prodrug . Drug Metab. Dispos. , 30 : 191 – 198 .
   PubMed Web of Science ®Google Scholar
• Lu , W , Zhang , Y , Tan , YZ , Hu , KL , Jiang , XG and Fu , SK . 2005 . Cationic albumin-conjugated pegylated nanoparticles as novel drug carrier for brain delivery . J. Controlled Release. , 107 : 428 – 448 .
   PubMed Web of Science ®Google Scholar
• Jalali , N , Moztarzadeh , F , Mozafari , M , Asgari , S , Motevalian , M and Alhosseini , SN . 2011 . Surface modification of poly (lactide-co-glycolide) nanoparticles by d–tocopheryl polyethylene glycol 1000 succinate as potential carrier for the delivery of drugs to the brain . Colloids Surf., A. , 392 : 335 – 342 .
   Google Scholar
• Hanson , LR and Frey , WH 2nd . 2008 . Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease . BMC Neurosci. , 9 : S5
   PubMed Web of Science ®Google Scholar
• Hanson , LR , Roeytenberg , A , Martinez , PM , Coppes , VG , Sweet , DC , Rao , RJ , Marti , DL , Hoekman , JD , Matthews , RB , Frey , WH 2nd and Panter , SS . 2009 . Intranasal deferoxamine provides increased brain exposure and significant protection in rat ischemic stroke . J. Pharmacol. Exp. Ther. , 330 : 679 – 686 .
   PubMed Web of Science ®Google Scholar
• Hashizume , R , Ozawa , T , Gryaznov , SM , Bollen , AW , Lamborn , KR , Frey , WH 2nd and Deen , DF . 2008 . New therapeutic approach for brain tumors: intranasal delivery of telomerase inhibitor GRN163 . Neuro Oncol. , 10 : 112 – 120 .
   PubMed Web of Science ®Google Scholar
• Liu , XF , Fawcett , JR , Hanson , LR and Frey , WH 2nd . 2004 . The window of opportunity for treatment of focal cerebral ischemic damage with noninvasive intranasal insulin-like growth factor-I in rats . J. Stroke Cerebrovasc. Dis. , 13 : 16 – 23 .
   PubMedGoogle Scholar
• Kissel , T and Werner , U . 1998 . Nasal delivery of peptides: an in vitro cell culture model for the investigation of transport and metabolism in human nasal epithelium . J. Control Release. , 53 : 195 – 203 .
   PubMed Web of Science ®Google Scholar
• Frey , WH 2nd . 2002 . Bypassing the blood-brain barrier to delivery therapeutic agents to the brain and spinal cord . Drug Delivery Technol. , 2 : 46 – 49 .
   Google Scholar
• Dhanda , DS , Frey , WH 2nd , Leopold , D and Kompella , UB . 2005 . Approaches for drug deposition in the human olfactory epithelium . Drug Delivery Technol. , 5 : 64 – 72 .
   Google Scholar
• Costantino , HR , Illum , L , Brandt , G , Johnson , PH and Quay , SC . 2007 . Intranasal delivery: physicochemical and therapeutic aspects . Int. J. Pharm. , 337 : 1 – 24 .
   PubMed Web of Science ®Google Scholar
• Belgamwar , VS , Patel , HS , Joshi , AS , Agrawal , A , Surana , SJ and Tekade , AR . 2011 . Design and development of nasal mucoadhesive microspheres containing tramadol HCl for CNS targeting . Drug Delivery. , 18 : 353 – 360 .
   PubMed Web of Science ®Google Scholar
• Mistrya , A , Stolnika , S and Illum , L . 2009 . Nanoparticles for direct nose-to-brain delivery of drugs . Int. J. Pharm. , 379 : 146 – 157 .
   PubMedGoogle Scholar
• Ali , J , Ali , M , Baboota , S , Sahni , JK , Ramassamy , C , Dao , L and Bhavna . 2010 . Potential of nanoparticulate drug delivery systems by intranasal administration . Curr. Pharm. Des. , 16 : 1644 – 1653 .
   PubMed Web of Science ®Google Scholar
• Roney , C , Kulkarni , P , Arora , V , Antich , P , Bonte , F , Wu , A , Mallikarjuana , NN , Manohar , S , Liang , HF , Kulkarni , AR , Sung , HW , Sairam , M and Aminabhavi , TM . 2005 . Targeted nanoparticles for drug delivery through the blood–brain barrier for Alzheimer’s disease . J. Control Release. , 108 : 193 – 214 .
   PubMed Web of Science ®Google Scholar
• Kumari , A , Yadav , SK and Yadav , SC . 2010 . Biodegradable polymeric nanoparticles based drug delivery systems . Colloids Surf., B. , 75 : 1 – 18 .
   PubMed Web of Science ®Google Scholar
• Couvreur , P , Kante , B , Roland , M , Guiot , P , Bauduin , P and Speiser , P . 1979 . Polycyanoacrylate nanocapsules as potential lysosomotropic carriers: preparation, morphological and sorptive properties . J. Pharm. Pharmacol. , 31 : 331 – 332 .
   PubMed Web of Science ®Google Scholar
• Krauland , AH and Bernkop-Schnurch , A . 2004 . Thiomers: development and in vitro evaluation of a peroral microparticulate peptide delivery system . Eur. J. Pharm. Biopharm. , 57 : 181 – 187 .
   PubMed Web of Science ®Google Scholar
• Prokop , A and Davidson , JM . 2008 . Nanovehicular intracellular delivery systems . J. Pharm. Sci. , 97 : 3518 – 3590 .
   PubMed Web of Science ®Google Scholar
• Vert , M , Mauduit , J and Li , S . 1994 . Biodegradation of PLA/GA polymers: increasing complexity . Biomaterials. , 15 : 1209 – 1213 .
   PubMed Web of Science ®Google Scholar
• Park , K . 1997 . Controlled drug delivery: challenges and strategies. , Washington , DC : American Chemical Society .
   Google Scholar
• Lu , Z , Bei , J and Wang , S . 1999 . A method for the preparation of polymeric nanocapsules without stabilizer . J. Control Release. , 61 : 107 – 112 .
   PubMed Web of Science ®Google Scholar
• Eastman Chemical Company. Vitamin E TPGS NF, Properties and applications., Kingsport, TN: Publication EFC-226A, October 1998.
   Google Scholar
• Fariss , MW and Zhang , JG . 2003 . Vitamin E therapy in Parkinson’s disease . Toxicology. , 189 : 129 – 146 .
   PubMed Web of Science ®Google Scholar
• Gonzalez-Mira , E , Egea , MA , Garcia , ML and Souto , EB . 2010 . Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC . Colloids Surf., B. , 81 : 412 – 421 .
   PubMed Web of Science ®Google Scholar
• Lalani J, Rathi M, Lalan M, Misra A. Protein functionalized tramadol-loaded PLGA nanoparticles: preparation, optimization, stability a pharmacodynamic studies. Drug Dev. Ind. Pharm. Forthcoming 2012.
   Google Scholar
• Zhang , X , Liu , J , Qiao , H , Liu , H , Ni , J , Zhang , W and Shi , Y . 2010 . Formulation optimization of dihydroartemisinin nanostructured lipid carrier using response surface methodology . Powder Technol. , 197 : 120 – 128 .
   Web of Science ®Google Scholar
• Kumar , VV , Chandrasekar , D , Ramakrishna , S , Kishan , V , Rao , YM and Diwan , PV . 2007 . Development and evaluation of nitrendipine loaded solid lipid nanoparticles: influence of wax and glyceride lipids on plasma pharmacokinetics . Int. J. Pharm. , 335 : 167 – 175 .
   PubMed Web of Science ®Google Scholar
• Varshosaz , J , Tabbakhian , M and Mohammadi , MY . 2010 . Formulation and optimization of solid lipid nanoparticles of buspirone HCl for enhancement of its oral bioavailability . J. Liposome Res. , 20 : 286 – 296 .
   PubMed Web of Science ®Google Scholar
• Yang , SC , Lu , LF , Cai , Y , Zhu , JB , Liang , BW and Yang , CZ . 1999 . Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain . J. Controlled Release. , 59 : 299 – 307 .
   PubMed Web of Science ®Google Scholar
• Pardeshi , CV , Rajput , PV , Belgamwar , VS and Tekade , AR . 2012 . Formulation, optimization and evaluation of spray-dried mucoadhesive microspheres as intranasal carriers for Valsartan . J. Microencapsulation. , 29 : 103 – 114 .
   PubMed Web of Science ®Google Scholar
• Mahajan , HS and Gattani , SG . 2009 . Nasal administration of ondansetron using a novel microspheres delivery system . Pharm. Dev. Technol. , 14 : 226 – 232 .
   PubMed Web of Science ®Google Scholar
• Aji Alex , MR , Chacko , AJ , Jose , S and Souto , EB . 2011 . Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting . Eur. J. Pharm. Sci. , 42 : 11 – 18 .
   PubMed Web of Science ®Google Scholar
• Sahoo , SK , Panyam , J , Prabha , S and Labhasetwar , V . 2002 . Residual polyvinyl alcohol associated with poly (D, L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake . J. Controlled Release. , 82 : 105 – 114 .
   PubMed Web of Science ®Google Scholar
• Mu , L and Feng , SS . 2003 . PLGA/TPGS nanoparticles for controlled release of paclitaxel: effects of the emulsifier and drug loading ratio . Pharm. Res. , 20 : 1864 – 1872 .
   PubMed Web of Science ®Google Scholar
• Feng , S and Huang , G . 2001 . Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers . J. Controlled Release. , 71 : 53 – 69 .
   PubMed Web of Science ®Google Scholar
• Guerrero , DQ , Fessi , H , All’emann , E and Doelker , E . 1996 . Influence of stabilizing agents and preparatives variables on the formation of poly (d, l-lactic acid) nanoparticles by an emulsification-diffusion technique . Int. J. Pharm. , 143 : 133 – 141 .
   Google Scholar
• Chacon , M , Molpeceres , J , Berges , L , Guzman , M and Aberturas , MR . 1999 . Stability and freeze-drying of cyclosporine loaded poly (D, L lactide-glycolide) carriers . Eur. J. Pharm. Sci. , 8 : 99 – 107 .
   PubMed Web of Science ®Google Scholar
• Lamprecht , A , Ubrich , N , Hombreiro Pérez , M , Lehr , C , Hoffman , M and Maincent , P . 2000 . Influences of process parameters on nanoparticles preparation performed by a double emulsion pressure homogenization technique . Int. J. Pharm. , 196 : 177 – 182 .
   PubMed Web of Science ®Google Scholar